Polidocanol - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for polidocanol and what is the scope of patent protection?
Polidocanol
is the generic ingredient in two branded drugs marketed by Chemisch Fbrk Krsslr and Provensis, and is included in two NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Polidocanol has ninety-seven patent family members in thirty countries.
Two suppliers are listed for this compound.
Summary for polidocanol
International Patents: | 97 |
US Patents: | 4 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 76 |
Clinical Trials: | 26 |
Patent Applications: | 4,557 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in polidocanol? | polidocanol excipients list |
DailyMed Link: | polidocanol at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for polidocanol
Generic Entry Date for polidocanol*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for polidocanol
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Phase 4 |
Johns Hopkins University | Phase 1 |
Massachusetts General Hospital | Phase 1 |
Pharmacology for polidocanol
Drug Class | Sclerosing Agent |
Mechanism of Action | Sclerosing Activity |
Physiological Effect | Vascular Sclerosing Activity |
Anatomical Therapeutic Chemical (ATC) Classes for polidocanol
US Patents and Regulatory Information for polidocanol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Chemisch Fbrk Krsslr | ASCLERA | polidocanol | SOLUTION;INTRAVENOUS | 021201-002 | Mar 30, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-002 | Dec 21, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for polidocanol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for polidocanol
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 20060130074 | METHODS OF PREPARING A FOAM COMPRISING A SCLEROSING AGENT | ⤷ Sign Up |
Slovenia | 1673293 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 2005048983 | ⤷ Sign Up | |
China | 1878706 | Apparatus and method for dispensing foam | ⤷ Sign Up |
Czech Republic | 2006315 | Terapeutická pena (Therapeutic foam) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.